ArticleRSC advances2024

Design, synthesis, and biological evaluation of novel quinoline-based EGFR/HER-2 dual-target inhibitors as potential anti-tumor agents.

Lamya H Al-Wahaibi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.